1. Home
  2. ACRS vs OWLT Comparison

ACRS vs OWLT Comparison

Compare ACRS & OWLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aclaris Therapeutics Inc.

ACRS

Aclaris Therapeutics Inc.

HOLD

Current Price

$3.06

Market Cap

311.0M

Sector

Health Care

ML Signal

HOLD

Logo Owlet Inc.

OWLT

Owlet Inc.

HOLD

Current Price

$7.33

Market Cap

318.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACRS
OWLT
Founded
2012
2013
Country
United States
United States
Employees
N/A
85
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
311.0M
318.6M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
ACRS
OWLT
Price
$3.06
$7.33
Analyst Decision
Strong Buy
Buy
Analyst Count
5
2
Target Price
$9.75
$20.00
AVG Volume (30 Days)
1.2M
175.9K
Earning Date
05-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
69.01
N/A
EPS
N/A
N/A
Revenue
$1,683,000.00
N/A
Revenue This Year
N/A
$37.02
Revenue Next Year
N/A
$22.14
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.05
$2.75
52 Week High
$4.89
$16.94

Technical Indicators

Market Signals
Indicator
ACRS
OWLT
Relative Strength Index (RSI) 43.84 24.09
Support Level $2.78 N/A
Resistance Level $3.46 $9.63
Average True Range (ATR) 0.21 0.82
MACD -0.03 -0.12
Stochastic Oscillator 44.53 4.77

Price Performance

Historical Comparison
ACRS
OWLT

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.

About OWLT Owlet Inc.

Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.

Share on Social Networks: